Intracoronary Versus Intravenous Abciximab Bolus Administration

We read with interest the recently published paper by Desch et al. (1) reporting on long-term clinical follow-up of the randomized AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction) trial.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Source Type: research